Announcements Trials
Browse Landscape

Phase

Phase NA 245Phase 2 55Phase 1 22Phase 3 20Phase EARLY_PHASE1 10Phase 1/2 10Phase 4 9Phase 2/3 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Parasomnias 1Fatigue 1Depression 1Anxiety Disorders 1Advanced Cancers 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Surveys and Questionnaires × Clear all
NCT02597478 2021-02-09

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

M.D. Anderson Cancer Center

Phase 2/3 Completed
50 enrolled 14 charts

Advanced Cancers

NCT01193530 2019-03-26

The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated
12 enrolled 3 charts

Anxiety Disorders, Depression, Fatigue, Parasomnias

NCT02163187 2018-02-05

Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

Memorial Sloan Kettering Cancer Center

Phase 2/3 Terminated
4 enrolled 5 charts
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡